C2 PHARMA EXPANDS OPHTHALMIC API PORTFOLIO WITH THE LAUNCH OF DORZOLAMIDE HYDROCHLORIDE Posted on 11. March 202611. March 2026 by admin_c2p
C2 PHARMA Receives C-DMF approval for Brimonidine Tartrate Posted on 4. March 20265. March 2026 by admin_c2p